CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells
-
Published:2022-03-09
Issue:9
Volume:64
Page:958-969
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Yang XiaowenORCID, Zhou Shilin, Yang Chunyue, Cao Chunyan, He Meijun, Zi Shuxia
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference34 articles.
1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394–424. 2. Muñoz-galván, S., Felipe-abrio, S., Verdugo-sivianes, B., Perez, E. M., Jiménez-garcía, M., Suarez-Martinez, M. P., Estevez-garcia, E., & Carnero, A. (2020). Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness. Molecular cancer, 19, 7–7. 3. Tang, J. X., Li, J., Cheng, J. M., Hu, B., Sun, T. C., Li, X. Y., Batool, A., Wang, Z. P., Wang, X. X., Deng, S. L., Zhang, Y., Chen, S. R., Huang, X., & Liu, Y. X. (2017). Requirement for CCNB1 in mouse spermatogenesis. Cell Death Disease, 8, e3142. 4. Krenning, L., Feringa, F. M., Shaltiel, I. A., van den Berg, J., & Medema, R. H. (2014). Transient activation of p53 in G2 phase is sufficient to induce senescence. Molecular Cell, 55, 59–72. 5. Malumbres, M., & Barbacid, M. (2009). Cell cycle, CDKs and cancer: A changing paradigm. Nature Reviews Cancer, 9, 153–166.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|